DRUG INTERACTIONS IN PROLANIS PATIENTS IN UPT PUSKESMAS IBRAHIM ADJIE BANDUNG, IN PERIOD OF OCTOBER â DECEMBER 2020
Prolanis (Chronic Disease Management Program) is a government program in the health care system and a proactive approach that is implemented in an integrated manner involving participants, Health Facilities and BPJS Health. The purpose of Prolanis is to encourage participants with chronic disease...
Saved in:
| Main Author: | |
|---|---|
| Format: | Theses |
| Language: | Indonesia |
| Online Access: | https://digilib.itb.ac.id/gdl/view/62990 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Institut Teknologi Bandung |
| Language: | Indonesia |
| Summary: | Prolanis (Chronic Disease Management Program) is a government program in the health care
system and a proactive approach that is implemented in an integrated manner involving
participants, Health Facilities and BPJS Health. The purpose of Prolanis is to encourage
participants with chronic diseases to achieve optimal quality of life with an indicator of 75%
of registered participants visiting the First Level Health Facilities having good results on
specific examinations of Type 2 DM and Hypertension according to the relevant Clinical
Guidelines so as to prevent complications from the disease. (Kementrian Kesehatan RI. 2016).
This study aims to describe the drug interactions of prolanis patients at UPT Puskesmas
Ibrahim Adjie in the period October-December 2020. This study involved 81 prescription
sheets. There are 12 prescription sheets that have the potential for drug interactions with a
total of 19 findings. The type of interaction that occurs the most is interaction with a moderate
degree of 73.68% and a major one of 26.32%. The type of drug interaction that occurs the most
is the type of pharmacodynamic interaction with 52,63%. Then the pharmacokinetic
interaction was 21,05%. Drug interaction between Lisinopril and Metformin is the most
commonly found with 26,32%.
|
|---|